Thu November 28 – 10 Stories of The Day!
28 Nov, 2019 | 10:51h | UTC
1 – Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Diagnosis of Pulmonary Embolism – American College of Cardiology (free)
2 – Aupplemental MRI Screening for Women with Extremely Dense Breast Tissue – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Does MRI Screening Benefit Women With Extremely Dense Breasts? – U.S. News (free) AND Mixed Results With Mammo Plus MRI Screening – MedPage Today (free)
“The benefits need to be carefully weighed against the harms, as MRI examination is more expensive, and it requires the injection of a contrast agent into the body. MRI will also detect abnormalities that later turn out not to be breast cancer after all” (from U.S News)
3 – Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Head-to-head comparison finds three anti-seizure drugs equally effective for severe form of epilepsy – NIH News Release (free)
Commentary: Depression in Docs Leads to Medical Errors and Vice Versa – Medscape (free registration required)
Commentaries: WHO Releases New HIV Testing Guidelines To Help Expand Treatment Coverage, Reduce HIV Transmission – Health Policy Watch (free) AND WHO releases new HIV testing guidelines – Global ID News (free)
Related: Immune Thrombocytopenia – Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI – Oncology Research and Treatment (free) AND Clinical updates in adult immune thrombocytopenia – Blood (free) AND Management of immune thrombocytopenia: Korean experts recommendation in 2017 – Blood Research (free)
Commentaries: FDA’s Warning On CBD: Cannabis Stocks Drop, Companies Object – Forbes (free) AND ‘CBD has the potential to harm you,’ FDA warns consumers – MarketWatch (free)
Related: Cannabidiol Products Are Everywhere, but Should People Be Using Them? – JAMA (free for a limited period) AND NICE Guideline: Cannabis-Based Medicinal Products (free Guideline and other resources)
8 – What Are the Benefits of Probiotics? – The New York Times (free)
Related: Systematic Review: Harms Reporting in Trials with Probiotics (link to abstract and commentaries) AND The Problem With Probiotics – The New York Times (free)
9 – News Release: Antibiotic-Resistant Bacteria More Prevalent in Device-Related Infections – Society for Healthcare Epidemiology of America (free)
Original Studies: Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017 – Infection Control & Hospital Epidemiology (free) AND Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017 – Infection Control & Hospital Epidemiology (free)
Commentary: CDC: Medical devices key source of antibiotic-resistant infections – CIDRAP (free)
Related meta-analysis: Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: dose–response meta-analysis of prospective cohort studies – European Journal of Epidemiology (free)